Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
- NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
- NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_assertion evidence source_evidence_literature NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
- NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_assertion SIO_000772 11433527 NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
- NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_assertion wasDerivedFrom befree-2016 NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
- NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_assertion wasGeneratedBy ECO_0000203 NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.
- befree-2016 importedOn "2016-02-19" NP322546.RACiMbekTxzme8XRA-vof1XfzmJxkln_wny-Ue31CCqew130_provenance.